Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
493M
-
Number of holders
-
353
-
Total 13F shares, excl. options
-
370M
-
Shares change
-
-3.2M
-
Total reported value, excl. options
-
$9.84B
-
Value change
-
-$152M
-
Put/Call ratio
-
1.91
-
Number of buys
-
218
-
Number of sells
-
-158
-
Price
-
$26.59
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q3 2019
443 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q3 2019.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 353 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 370M shares
of 493M outstanding shares and own 75.09% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (37.2M shares), VANGUARD GROUP INC (33.8M shares), WELLINGTON MANAGEMENT GROUP LLP (32.1M shares), PRIMECAP MANAGEMENT CO/CA/ (30.4M shares), BlackRock Inc. (18.8M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (15M shares), LAZARD ASSET MANAGEMENT LLC (13.8M shares), Invesco Ltd. (13.2M shares), AMUNDI PIONEER ASSET MANAGEMENT INC (11M shares), and STATE STREET CORP (9.76M shares).
This table shows the top 353 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.